← Holders
Nan Fung Group Holdings Ltd
What Nan Fung Group Holdings Ltd reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1782539 · Filed Nov 13, 2026
- Positions
- 29
- Reported value
- $149.7M
- Opened
- 5
- Closed
- 1
- Other managers included
- 2
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$59.6M24 positions
- Dec 31, 2025$111.7M27 positions
- Mar 31, 2026$121.3M24 positions
- Jun 30, 2026$131.5M25 positions
- Sep 30, 2026$149.7M29 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
LBRXLB Pharmaceuticals Inc | 630.7K | ±0% | $24.2M | 16.2% |
MPLTMapLight Therapeutics, Inc. | 2.3M | +136.8% | $23.4M | 15.7% |
OBXObsidian Therapeutics, Inc. | 918.8K | New | $12.6M | 8.4% |
HELPHelus Pharma Inc. | 987.2K | ±0% | $12.1M | 8.1% |
EVMNEvommune, Inc. | 1.4M | ±0% | $11.9M | 8% |
NUVBNuvation Bio Inc. | 1.3M | New | $7.4M | 5% |
INCYIncyte Corp | 53.7K | ±0% | $6.5M | 4.4% |
ONCBeOne Medicines Ltd. | 15.7K | ±0% | $5.8M | 3.8% |
RYTMRhythm Pharmaceuticals, Inc. | 49.1K | ±0% | $4.7M | 3.1% |
PCORProcore Technologies, Inc. | 88.8K | +66.7% | $4.6M | 3.1% |
NAMSNewAmsterdam Pharma Co N.V. | 165K | New | $4M | 2.7% |
RVMDRevolution Medicines, Inc. | 19.3K | ±0% | $4M | 2.6% |
KYMRKymera Therapeutics, Inc. | 30.9K | ±0% | $3.5M | 2.3% |
ASNDAscendis Pharma A/S | 13.6K | ±0% | $3.1M | 2.1% |
MDGLMadrigal Pharmaceuticals, Inc. | 5.7K | ±0% | $2.9M | 1.9% |
OCSOculis Holding AG | 300.6K | ±0% | $2.8M | 1.9% |
ARGXArgenx SE | 2.8K | ±0% | $2.7M | 1.8% |
TCGXTCGX Acquisition Corp. | 200K | New | $2.5M | 1.7% |
CELCCelcuity Inc. | 28.3K | ±0% | $2.3M | 1.5% |
ACADAcadia Pharmaceuticals Inc | 103K | ±0% | $2.1M | 1.4% |
BRVEBraveheart Bio, Inc. | 81.4K | New | $1.6M | 1.1% |
HRMYHarmony Biosciences Holdings, Inc. | 27K | ±0% | $1.1M | 0.7% |
ETHAiShares Ethereum Trust ETF | 50.5K | ±0% | $1M | 0.7% |
IBITiShares Bitcoin Trust ETF | 16K | ±0% | $755.9K | 0.5% |
INSMInsmed Inc | 6.6K | ±0% | $751K | 0.5% |
RXRXRecursion Pharmaceuticals, Inc. | 181.6K | −69.5% | $750.1K | 0.5% |
RANIRani Therapeutics Holdings, Inc. | 493.6K | ±0% | $390.4K | 0.3% |
TRDAEntrada Therapeutics, Inc. | 49.1K | ±0% | $311.7K | 0.2% |
BOLTBolt Biotherapeutics, Inc. | 5K | ±0% | $18.4K | 0.1% |